Clinical trialNCT01152554CompletedPhase 3Interventional

A Study to Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder

SponsorAstraZenecaEnrollment813DepressionMDDMajor Depressive Disorder

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Andrew . J Cutler, MD
Florida Clinical Research Center, LLC
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗
Hans A. Eriksson, MD, Ph.D, MBA
AstraZeneca
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

94 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Puerto Rico

Research Site
San Juan, Puerto Rico

United States

Research Site
Birmingham, Alabama, United States
Research Site
Tuscaloosa, Alabama, United States
Research Site
Tucson, Arizona, United States
Research Site
Little Rock, Arkansas, United States
Research Site
Arcadia, California, United States
Research Site
Beverly Hills, California, United States
Research Site
Carson, California, United States
Research Site
Cerritos, California, United States
Research Site
Chino, California, United States
Research Site
Costa Mesa, California, United States
Research Site
Encino, California, United States
Research Site
Escondido, California, United States
Research Site
Garden Grove, California, United States
Research Site
Irvine, California, United States
Research Site
Los Alamitos, California, United States
Research Site
Los Angeles, California, United States
Research Site
Newport Beach, California, United States
Research Site
Pico Rivera, California, United States
Research Site
Riverside, California, United States
Research Site
Sherman Oaks, California, United States
Research Site
Torrance, California, United States
Research Site
Upland, California, United States
Research Site
Denver, Colorado, United States
Research Site
Norwalk, Connecticut, United States
Research Site
Norwich, Connecticut, United States
Research Site
Bradenton, Florida, United States
Research Site
Coral Springs, Florida, United States
Research Site
Fort Myers, Florida, United States
Research Site
Gainsville, Florida, United States
Research Site
Jacksonville, Florida, United States
Research Site
Maitland, Florida, United States
Research Site
North Miami, Florida, United States
Research Site
Orange City, Florida, United States
Research Site
Orlando, Florida, United States
Research Site
Pinecrest, Florida, United States
Research Site
Plantation, Florida, United States
Research Site
St. Petersburg, Florida, United States
Research Site
Tampa, Florida, United States
Research Site
West Palm Beach, Florida, United States

54 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Jun 2010
Primary completion: 29 Feb 2012
Completion: 29 Feb 2012
Last update posted: 11 Apr 2014
Registered enrollment: 813
Registry id: NCT01152554

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.